Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

pH‐Responsive Polymer Nanoparticles for Efficient Delivery of Cas9 Ribonucleoprotein With or Without Donor DNA
Ruosen Xie, Xiuxiu Wang, Yuyuan Wang, et al.
Advanced Materials (2022) Vol. 34, Iss. 23
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

A bimetallic nanoplatform for STING activation and CRISPR/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses
Ying Huang, Geng Qin, Tingting Cui, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Impairing Tumor Metabolic Plasticity via a Stable Metal‐Phenolic‐Based Polymeric Nanomedicine to Suppress Colorectal Cancer
Xiaoling Li, Zhenyu Duan, Xiaoting Chen, et al.
Advanced Materials (2023) Vol. 35, Iss. 23
Closed Access | Times Cited: 69
Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders
Echuan Tan, Tao Wan, Qi Pan, et al.
Science Advances (2024) Vol. 10, Iss. 16
Open Access | Times Cited: 17
Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression
Jing Fang, Yali Feng, Yuqi Zhang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 50, pp. 23061-23072
Closed Access | Times Cited: 41
Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing
Zoya Iqbal, Khurrum Rehman, Jiang Xia, et al.
Biomaterials Science (2023) Vol. 11, Iss. 11, pp. 3762-3783
Closed Access | Times Cited: 38
Biomaterial‐based gene therapy
Yi Yu, Yijun Gao, Liming He, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 36
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
Ke Yi, Huimin Kong, Yeh‐Hsing Lao, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 30
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Recent developments of polymeric delivery systems in gene therapeutics
Yijia Li, Ruizhen Tian, Jiayun Xu, et al.
Polymer Chemistry (2024) Vol. 15, Iss. 19, pp. 1908-1931
Closed Access | Times Cited: 10
Advances in Nanoparticles as Non-Viral Vectors for Efficient Delivery of CRISPR/Cas9
Minse Kim, Youngwoo Hwang, Seongyu Lim, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1197-1197
Open Access | Times Cited: 10
CRISPR–Cas9 delivery strategies for the modulation of immune and non-immune cells
Shahad K. Alsaiari, Behnaz Eshaghi, Bujie Du, et al.
Nature Reviews Materials (2024)
Closed Access | Times Cited: 10
Oxygen generating biomaterials at the forefront of regenerative medicine: advances in bone regeneration
Jiayi Zhao, Chao Zhou, Xiao Yang, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 9
CRISPR/Cas systems for genomic Editing, biochemical Sensing, Bioanalysis, and diagnostics
Mirza Muhammad Faran Ashraf Baig, Sek Ying Chair, Wai Tong Chien
Microchemical Journal (2025), pp. 112638-112638
Closed Access | Times Cited: 1
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing
Tianxu Fang, Xiaona Cao, Mysha Ibnat, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31
Development of delivery strategies for CRISPR‐Cas9 genome editing
Qi Liu, Jianhui Yang, Yumeng Xing, et al.
BMEMat (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 20
Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery
Yi Lin, Xianjin Luo, Tobias Burghardt, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 28, pp. 15171-15179
Open Access | Times Cited: 18
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
Shuying Feng, Xin Xie, Junjie Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases
Simone Pinto Carneiro, Antonietta Greco, Enrica Chiesa, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 4, pp. 471-487
Open Access | Times Cited: 14
Magnetic Nanoparticle‐Assisted Non‐Viral CRISPR‐Cas9 for Enhanced Genome Editing to Treat Rett Syndrome
Hyeon‐Yeol Cho, Myungsik Yoo, Thanapat Pongkulapa, et al.
Advanced Science (2024) Vol. 11, Iss. 24
Open Access | Times Cited: 6
Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases
Lanjie Lei, Wenjie Pan, Xin Shou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection
Huimin Kong, Chenya Zhuo, Ke Yi, et al.
Nano Today (2023) Vol. 53, pp. 102040-102040
Closed Access | Times Cited: 13
An in situ protonation-activated supramolecular self-assembly for selective suppression of tumor growth
Xuan Wu, Ming Liu, Jie Niu, et al.
Chemical Science (2023) Vol. 14, Iss. 7, pp. 1724-1731
Open Access | Times Cited: 12
Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles
Min Zhu, Xiuxiu Wang, Ruosen Xie, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 8, pp. 10464-10476
Closed Access | Times Cited: 12
Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery
Panqin Ma, Qi Wang, Xi Luo, et al.
Biomaterials Science (2023) Vol. 11, Iss. 15, pp. 5078-5094
Closed Access | Times Cited: 12
CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives
Guofang Chen, Tingyi Wei, Hui Yang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2964-2964
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top